# Safety and Efficacy of Measles, Mumps, Rubella Vaccination in Pediatric Heart Transplantation Patients

> **NCT07195032** · PHASE4 · RECRUITING · sponsor: **Children's Mercy Hospital Kansas City** · enrollment: 60 (estimated)

## Conditions studied

- Heart Transplant Infection Prevention

## Interventions

- **DRUG:** Commercial measles, mumps, and rubella (MMR) vaccine

## Key facts

- **NCT ID:** NCT07195032
- **Lead sponsor:** Children's Mercy Hospital Kansas City
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-11
- **Primary completion:** 2027-09-11
- **Final completion:** 2027-09-11
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07195032

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07195032, "Safety and Efficacy of Measles, Mumps, Rubella Vaccination in Pediatric Heart Transplantation Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07195032. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*